Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Thursday. The brokerage issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of Ampio Pharmaceuticals stock opened at $0.00 on Thursday. The company has a 50 day moving average of $0.02 and a 200-day moving average of $0.43. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $7.47. The company has a market cap of $2,508.00, a PE ratio of 0.00 and a beta of 3.67.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.